Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
In the field of urology, sacral neuromodulation (SNM) is a well-accepted, second-line, minimally invasive treatment for patients with overactive bladder dry (OABD) or wet (OABW), and for patients with non-obstructive urinary retention (NOUR).
Long-term vary between 50-60%. This study examines whether urodynamics can be used as a predictor for successful SNM therapy
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Successes | Patients with >50% improvement during test procedure of sacral neuromodulation. |
| |
| Failures | Patients with <50% improvement during test procedure of sacral neuromodulation. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| urodynamics | Diagnostic Test | Bladder filling and pressure is measured by the insertion of probes within the bladder, urethra and anorectum. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Change in bladder volume | Change in bladder volume is measured before and after test procedure for sacral neuromodulation | 3 weeks |
| Change in bladder sensation | Bladder sensation is measured by a slider (indicating bladder fullness scaled from 0 to 100) before and after test procedure for sacral neuromodulation | 3 weeks |
| Change in ice water test | Ice water is infused in the bladder and incontinence upon insertion of the ice water is assessed before and after sacral neuromodulation | 3 weeks |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patient with overactive bladder or non-obstructive urinary retention.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Stefan De Wachter, MD PhD FEBU | Contact | 8215934 | 323 | stefan.dewachter@antwerpen.be |
| Name | Affiliation | Role |
|---|---|---|
| Stefan De Wachter, MD PhD FEBU | University Hospital, Antwerp | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of antwerp | Recruiting | Antwerp | Edegem | 2650 | Belgium |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D053201 | Urinary Bladder, Overactive |
| ID | Term |
|---|---|
| D001745 | Urinary Bladder Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
Not provided
Not provided
| ID | Term |
|---|---|
| D014563 | Urodynamics |
| ID | Term |
|---|---|
| D014553 | Urinary Tract Physiological Phenomena |
| D012101 | Reproductive and Urinary Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
|
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D059411 | Lower Urinary Tract Symptoms |
| D020924 | Urological Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |